In 2016, a tiny Bay Area start-up announced an experiment that seemed equal parts medieval sorcery and science fiction: It would inject older people with the blood plasma of young donors in a bid to slow aging. For three years, Ambrosia Chief Executive Jesse Karmazin charged patients $8,000 to...